WASHINGTON DC (April 1, 2019) — The US Food and Drug Administration (USFDA) today posted warning letters to four companies who produce homeopathic drug-products for significant violations of current good manufacturing practice (CGMP) regulations, including a letter to King Bio Inc of Asheville, NC.